Derivatives 2026 Comparisons

In Hong Kong, the derivatives markets are divided into exchange-traded derivatives and non-centrally cleared (also known as over-the-counter, OTC) derivatives. Exchange-traded derivatives in Hong Kong are primarily traded on the Hong Kong Futures Exchange (HKFE) and cleared through HKEX clearing houses, featuring widely used products like Hang Seng Index (HSI) futures and options. OTC derivatives are private contracts directly negotiated between parties and commonly follow master agreements such as those published by the International Swaps and Derivatives Association (ISDA).

The two principal pieces of subsidiary legislation to the Securities and Futures Ordinance (SFO) now in operation form the majority of the regulatory framework over OTC derivatives trades. The reporting limb is principally contained in the Securities and Futures (OTC Derivative Transactions – Reporting and Record Keeping Obligations) Rules, Cap. 571AL, which impose reporting obligations under Section 101B of the SFO and related record-keeping obligations under Section 101E. The clearing limb is principally contained in the Securities and Futures (OTC Derivative Transactions – Clearing and Record Keeping Obligations and Designation of Central Counterparties) Rules, Cap. 571AN, which implement the clearing obligation under Section 101C, related record-keeping obligations under Section 101E, and the designation of central counterparties under Section 101J. The Securities and Futures Commission’s legislative history records that Cap. 571AN came into operation on 1 September 2016.

Locally, OTC derivatives compliance work is mainly focused on areas such as reporting, clearing, risk mitigation and margin. Particularly for SFC-regulated groups, the more relevant live issues include reporting to the Hong Kong Trade Repository (HKTR), clearing threshold monitoring, affiliate and booking-model governance, uncleared margin and risk mitigation controls, the prospective capital effect of the Financial Resources Rules (FRR) changes and proposed Type 11 and Type 12 regulated activities framework under the SFO and its sub-legislation.

Since the global financial crisis in 2008, regulators and authorities have moved towards improving transparency and reduce counterparty risks in the OTC derivatives markets, resulting in reforms to the OTC derivatives markets on various fronts. From 2011 onwards, the Securities and Futures Commission (SFC) released a series of consultation conclusion by phases to bolster the OTC derivatives regulatory framework, including amendments to the Securities and Futures Ordinance (SFO) and its subsidiary legislations to address mandatory clearing and reporting obligations, as well as changes to licensing and capital regimes. (For a more in-depth analysis of the regulated activities reform introduced by the Securities and Futures (Amendment) Ordinance 2014, see the Trends and Developments chapter of this guide.) The exchange-traded derivatives regime is also undergoing reforms such as the Investor Identification Regime for which a consultation paper was issued by the SFC in June 2026 to further bolster the integrity and sustainable development of Hong Kong’s capital markets.

Being private and more variable in nature, the OTC derivatives market in Hong Kong is experiencing larger changes and therefore facing more impact as a result of new regulatory requirements as well as market changes. This chapter of the guide will also focus more on the OTC derivatives markets and reference the exchange-traded derivatives market where relevant.

In Hong Kong, the main listed futures and options on futures are equity index (for example, HSI, HSCEI, Hang Seng TECH), single-stock, FX (USD/CNH and other CNH pairs), interest rate (HIBOR), and commodity contracts (gold, silver and LME mini metals), with options on key equity index futures and flexible index options also widely traded. Innovative developments over the past 12 months include continued expansion of MSCI index futures and options and more CNH denominated contracts, while crypto futures remain largely offshore and are not a core HKEX product segment. Traditional commodity futures are physically or cash settled against tangible underlyings and linked to global benchmarks, whereas any crypto linked products available to Hong Kong investors tend to be cash settled, higher volatility, and accessed via overseas venues or structured products rather than HKEX futures.

Swaps in Hong Kong predominantly trade over the counter and are cleared through OTC Clear, HKEX’s central counterparty for IRS, cross-currency swaps, non-deliverable currency forwards and deliverable FX. The SFC implements an OTC derivatives regime under the SFO, including mandatory clearing and reporting obligations for certain interest rate and FX derivatives, and licensing requirements for dealers and clearing participants. Cleared swaps benefit from CCP multilateral netting, standardised margin and collateral arrangements, and regulatory recognition of reduced counterparty credit risk, whereas uncleared swaps remain subject to bilateral credit support documentation, higher capital and margin expectations, and more intensive conduct and risk management oversight.

Forwards in Hong Kong are generally treated as OTC derivatives under the SFO and associated OTC derivatives regime rather than as “futures contracts” traded on HKEX, with non-deliverable forwards and FX forwards qualifying as eligible products for clearing at OTC Clear. The SFC’s framework subjects specified forwards to transaction reporting, mandatory clearing (where in scope), and licensing obligations for institutions dealing, advising or providing clearing services in relation to such contracts. Deliverable FX forwards and FX swaps cleared through OTC Clear follow CCP rules on product eligibility, margin, collateral and default management, supplementing bilateral ISDA and credit support documentation that apply when trades remain uncleared.

Exchange traded derivatives in Hong Kong, such as HKEX futures and options, must comply with listing and product approval requirements, trade via recognised exchange platforms, and be centrally cleared through HKCC or other HKEX CCPs under detailed rulebooks governing margin, position limits and default procedures. Over-the-counter derivatives are subject instead to the SFC’s OTC derivatives regime, mandatory trade reporting, clearing requirements for certain product classes, and applicable regulatory requirements for relevant market participants (references to Type 11 and Type 12 regulated activities should be treated with care, as those categories exist in the statutory framework but are not yet in operation for licensing purposes). In practice, this means exchange traded products face more standardised contract terms and transparency obligations, whereas OTC derivatives allow bespoke structuring but attract more stringent bilateral risk management, documentation and regulatory compliance burdens.

There are two principal classes of collateral assets that are generally acceptable in Hong Kong as credit support for obligations under derivatives documentation: (i) cash and liquid equity; and (ii) fixed-income securities such as listed shares, US treasuries, corporate bonds and other readily marketable debt securities. Marketable debt securities are often issued or fully guaranteed by a sovereign, a relevant international organisation, a multilateral development bank or a public sector entity. The specific types of acceptable assets may depend on the nature of the transaction and the creditworthiness of the parties involved. In Hong Kong, where the counterparty borrower is a sizeable PRC corporation and when it enters into hedges in connection with its underlying loan obligations, it is also common to see the use of standby letters of credit issued by a third-party bank as credit support.

Since mid-2024, the Hong Kong Monetary Authority (HKMA) has signalled plans to expand eligible collateral to include e-HKD and licensed stablecoins (eg, USDC/USDT) for variation margin (VM), and green bonds for initial margin (IM), but with no formal approval yet. Participants should monitor HKMA circulars for form adoption timelines.

Certain types of products are exempt from the Margin Rules (see 4.1.2 Margins), otherwise authorised institutions (AIs) are required to adopt margins and other risk mitigation standards for all OTC derivatives transactions. These exempted products include:

• transactions such as repurchase agreements and securities lending transactions that are not themselves derivatives but share some attributes with derivatives;
• indirectly cleared derivatives;
• physically settled FX forwards and FX swaps, and the “FX transactions” embedded in cross-currency swaps associated with the exchange of principal;
• physically settled commodity forwards; and
• non-centrally cleared single-stock options, equity basket options and equity index options.

In terms of retail forex transactions, spot forex without leverage generally does not require a licence. However, Leveraged Foreign Exchange Trading (LFET) – commonly used in retail forex – is classified as a regulated activity (Type 3) and strictly overseen by the SFC. Any firm offering leveraged forex trading services to the Hong Kong public must be licensed by the SFC or registered with the HKMA as an authorised institution (AI). However, companies exempt from the licensing requirement under the Securities and Futures Ordinance by virtue of the Securities and Futures (Leveraged Foreign Exchange Trading-Exemption) Rules are not subject to any regulation in their LFET activities.

From the SFC’s Report on Leveraged Foreign Exchange Trading Activities Carried Out by Licensed Corporations published in April 2020, as a regulated activity licence holder, LFET brokers are subject to the same duties to act honestly, fairly, with due skill, care and diligence, and in the best interests of their clients when handling client orders under the Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission.

Hong Kong is a single jurisdiction with no state, provincial or municipal tier of regulation. Regulatory authority is exercised at the level of the Hong Kong Special Administrative Region by the SFC and the HKMA, as described in 3.1.1 National Regulators.

Although Hong Kong is part of the People’s Republic of China, under the “one country, two systems” principle and the Basic Law, it maintains a separate legal system and its own financial regulators, and the national laws of Mainland China generally do not apply. In practice, Mainland China regulators such as the China Securities Regulatory Commission and the People’s Bank of China have no direct authority over the Hong Kong derivatives market; cross-boundary initiatives, such as Swap Connect, instead operate through co-operation between the two regimes, with each side regulating its own participants.

Hong Kong does not rely on self-regulatory organisations exercising delegated statutory powers over their members; regulation is centralised in the SFC and the HKMA. The principal market infrastructure is operated by HKEX, itself a recognised exchange controller regulated by the SFC.

HKEX operates The Stock Exchange of Hong Kong Limited (SEHK) and the Hong Kong Futures Exchange Limited (HKFE), each a recognised exchange company under the SFO, together with the associated recognised clearing houses, including HKCC, SEOCH, the Hong Kong Securities Clearing Company Limited, and OTC Clear. The HKFE is the venue for exchange-traded futures and options and administers its own rules and contract specifications under SFC oversight.

Industry bodies such as the Treasury Markets Association and the International Swaps and Derivatives Association play an influential role in market practice and standard documentation, but they are trade associations rather than regulators and do not exercise statutory authority. All of this infrastructure is subject to SFC oversight, and there is no separate local-level supervision.

For derivatives transactions adopting the documentation framework of the ISDA Master Agreement, ISDA has commissioned Hong Kong legal opinions in respect of the enforceability of close-out netting and/or set-off provisions in derivatives documentation.

Solvency of parties is often a key issue to clearing brokers and their customers. Where parties are solvent, contractual netting and set-off provisions in the ISDA Master Agreement are generally enforceable in Hong Kong. There are several forms of set-off in Hong Kong, and contractual set-off pursuant to an agreement is generally enforceable.

However, if a counterparty is insolvent, then statutory/insolvency set-off would apply to mutual credits, mutual debts and other liabilities arising out of mutual dealings. The application of statutory/insolvency set-off is mandatory and cannot be contracted out of. Netting and set-off provisions under an ISDA Master Agreement are likely to comply with statutory/insolvency set-off requirements.

The ISDA commissions netting and collateral opinions on the enforceability of netting provisions, termination, bilateral close-out netting and multibranch netting provisions, as well as credit support documents in various jurisdictions including Hong Kong. There are no derivative-specific execution requirements under Hong Kong law, but opinions ensure corporate counterparties are legally bound and that trades survive insolvency. Typically, ISDA Master Agreements serve to verify four core pillars:

• capacity;
• authority;
• enforceability (including termination netting); and
• collateral validity.

As explained above, the major developments in enforcement trends in recent years focus more on OTC derivatives as opposed to exchange-traded derivatives. Currently, the dedicated OTC derivatives licensing regime introduced by the Securities and Futures (Amendment) Ordinance 2014, including Type 11 and Type 12 regulated activities, remains introduced in the statutory architecture but is still not yet in operation for licensing purposes. The SFC’s current licensing materials list Type 11 as “dealing in OTC derivative products or advising on OTC derivative products” and Type 12 as “providing client clearing services for OTC derivative transactions”, but mark both as not yet in operation for licensing purposes.

The proposed amendments are in advanced stages such that groups should already assess whether their present business would, once commencement occurs, fall within expanded Type 7, expanded Type 9, Type 11 or Type 12. The SFC’s 2025 OTC derivatives activities survey expressly targeted firms whose activities would fall within expanded Type 7, Type 11 or Type 12 when the licensing regime introduced by the 2014 Amendment Ordinance comes into effect.

While both the HKMA and SFC regularly review local markets and provide guidance to the general public in relation to compliance and surveillance issues, it remains a general theme of development in enforcement trends that regulators strive to improve transparency and reduce counterparty risks, especially in OTC derivatives transactions. For a more detailed examination of the latest reforms, see the Trends and Developments chapter of this guide.